Detail page

Knowledge Web

Person

Michael Hust (1972-)

Biologe

Name	Michael Hust
Time	1972- (Date of birth and death)
Place	Braunschweig (Wirkungsort) Oldenburg (Oldenburg) (Geburtsort) Deutschland
Academic degree	Prof. Dr.
Profession	Biologe (characteristic profession)
Related	Technische Universität Braunschweig. Abteilung Biotechnologie Technische Universität Braunschweig. Institut für Biochemie, Biotechnologie und Bioinformatik
Further information	Habil. Lehrgebiet Biotechnologie, Fakultät Lebenswissenschaften der Techn. Univ. Braunschweig; Diss. Fachbereich Biologie der Univ. Hannover
Record type	Person
GND-Identifier	124252605
Record ID	124252605
Involved in show all Combining phage display with mammalian display Development of a new production strategy for recombinant HBsAg virus-like particles suitable for serological screening and structural investigations Development of a novel vaccination strategy against Chagas disease Dissecting molecular and immunological mechanisms of influenza vaccine responsiveness Identification of host and microbial signals influencing trans-kingdom crosstalk in the intestine Development of inhibiting antibodies against equine interleukin-5 and equine interleukin-31 to treat insect bite hypersensitivity of horses Engineering a high affine NMDAR-Fc “baitbody” fusion protein for autoantibody detection and elimination in NMDAR encephalitis Investigating the contribution of the intestinal microbiota to disease onset and treatment success in distinct types of rheumatic diseases Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathy Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant Generation of monoclonal antibodies against merozoites of the human parasite Plasmodium falciparum Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein Phage display-based discovery of cyclic peptides against the broad spectrum bacterial anti-virulence target CsrA The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockade Development of an inhibiting antibody against equine interleukin 5 to treat insect bite hypersensitivity of horses Investigation of Staphylococcus aureus intracellular survival strategies using a photoconvertible reporter system as biosensor for bacterial metabolic state Lichtabhängige Bakteriochlorophyllbiosynthese des marinen Bakteriums Dinoroseobacter shibae Light-dependent regulation of photosynthesis genes in Dinoroseobacter shibae Removing the major allergen Bra j I from brown mustard (Brassica juncea) by CRISPR/Cas9 Baculovirus-free insect cell expression system for high yield antibody and antigen production Development of neutralizing and non-neutralizing antibodies targeting known and novel epitopes on Clostridioides difficile Toxin B Intein mediated high throughput screening for bispecific antibodies Intrabodies – Selektionsverfahren aus humanen naïven Antikörper Repertoires Development of recombinant human anti-diphtheria toxin neutralizing antibodies for diphtheria therapy Entwicklung einer API-Produktionsplattform mittels CRISPR/Cas9 auf Basis einer CHO Zelllinie Rekombinante Antikörper : Lehrbuch und Kompendium für Studium und Praxis Rekombinante Antikörper : Lehrbuch und Kompendium für Studium und Praxis Use of phage display technologies for target discovery, antibody generation, and antigen-antibody interaction studies to develop a Listeria spp. detection Whole Genome Analysis and Biomarker Identification of Leptospira spp. Bacterial flagellar capping proteins adopt diverse oligomeric states Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes : a neutralizing V3- and a trimer-specific gp41 antibody Antibody phage display for proteome research, diagnostics and therapy Rekombinante Antikörper gegen die NIa-Protease des Plum pox virus Rekombinante Antikörper gegen die NIa-Protease des Plum pox virus

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Michael Hust (1972-)

Combining phage display with mammalian display

Development of a new production strategy for recombinant HBsAg virus-like particles suitable for serological screening and structural investigations

Development of a novel vaccination strategy against Chagas disease

Dissecting molecular and immunological mechanisms of influenza vaccine responsiveness

Identification of host and microbial signals influencing trans-kingdom crosstalk in the intestine

Development of inhibiting antibodies against equine interleukin-5 and equine interleukin-31 to treat insect bite hypersensitivity of horses

Engineering a high affine NMDAR-Fc “baitbody” fusion protein for autoantibody detection and elimination in NMDAR encephalitis

Investigating the contribution of the intestinal microbiota to disease onset and treatment success in distinct types of rheumatic diseases

Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathy

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

Generation of monoclonal antibodies against merozoites of the human parasite Plasmodium falciparum

Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein

Phage display-based discovery of cyclic peptides against the broad spectrum bacterial anti-virulence target CsrA

The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockade

Development of an inhibiting antibody against equine interleukin 5 to treat insect bite hypersensitivity of horses

Investigation of Staphylococcus aureus intracellular survival strategies using a photoconvertible reporter system as biosensor for bacterial metabolic state

Lichtabhängige Bakteriochlorophyllbiosynthese des marinen Bakteriums Dinoroseobacter shibae

Light-dependent regulation of photosynthesis genes in Dinoroseobacter shibae

Removing the major allergen Bra j I from brown mustard (Brassica juncea) by CRISPR/Cas9

Baculovirus-free insect cell expression system for high yield antibody and antigen production

Development of neutralizing and non-neutralizing antibodies targeting known and novel epitopes on Clostridioides difficile Toxin B

Intein mediated high throughput screening for bispecific antibodies

Intrabodies – Selektionsverfahren aus humanen naïven Antikörper Repertoires

Development of recombinant human anti-diphtheria toxin neutralizing antibodies for diphtheria therapy

Entwicklung einer API-Produktionsplattform mittels CRISPR/Cas9 auf Basis einer CHO Zelllinie

Rekombinante Antikörper : Lehrbuch und Kompendium für Studium und Praxis

Rekombinante Antikörper : Lehrbuch und Kompendium für Studium und Praxis

Use of phage display technologies for target discovery, antibody generation, and antigen-antibody interaction studies to develop a Listeria spp. detection

Whole Genome Analysis and Biomarker Identification of Leptospira spp.

Bacterial flagellar capping proteins adopt diverse oligomeric states

Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes : a neutralizing V3- and a trimer-specific gp41 antibody

Antibody phage display for proteome research, diagnostics and therapy

Rekombinante Antikörper gegen die NIa-Protease des Plum pox virus

Rekombinante Antikörper gegen die NIa-Protease des Plum pox virus